Cancer immunotherapy represents a major advance in the cure of cancer following the dramatic advancements in the development and refinement of chemotherapies and radiotherapies. In the recent decades, together
With the new advances in molecular and tumor biology, new development of technology in “-omics” and data analysis, there have been dramatic successes in the cancer immunotherapy recently. Targeting the immune checkpoint pathways to activate the host immune system against cancer cells is one such ...
While discussing the potential biomarkers involved in the initiation and progression of BC, we aimed to provide comprehensive insights into the immunotherapy and articulate the recent advances in terms of the therapeutic strategies used to control this disease, including immune checkpoint inhibitors, ...
The cancer immunotherapy is being emerged nowadays as a promising therapeutic modality in order to achieve a highly efficient therapeutic performance while circumventing tumor metastasis and relapse. Liposomal nanoparticles (NPs) may serve as an ideal platform for systemic delivery of the immune ...
urological cancerCancer immunotherapy for urological tumors had made progress for several decades, but recent advances in immunotherapy, as therapeutic vaccines or immune checkpoint inhibitors, have drastically changed the present treatment strategy. Recently, nivolumab and atezolizumab have been approved by ...
This international thematic series published in Journal of Hematology & Oncology provides an analysis of the latest developments in the field of cancer immunotherapy. The series is guest edited by Dr. Xiao-Jie Lu. Articles published in the collection have already gone through the systematic peer ...
Recently, immunotherapy has revolutionized cancer care and has garnered approval in many different solid tumors, including melanoma, lung cancer, and urothelial cancers, among others[16]. Therefore, it has been of great interest to explore the role of various immunotherapies in PDAC. Overall, result...
The incidence and mortality of cancer are the major health issue worldwide. Apart from the treatments developed to date, the unsatisfactory therapeutic effects of cancers have not been addressed by broadening the toolbox. The advent of immunotherapy has
Recent achievements in immunotherapy such as immne checkpoint inhibitors and chimeric antigen receptor T-cell therapy have revolutionized cancer treatments. By leveraging the patient’s own immune system, immunotherapy can now be applied in other disease contexts, including cardiac fibrosis and autoimmune ...
Graphic summary of recent advances in immunotherapy for advanced biliary tract cancer Immune Checkpoint Inhibitor (ICI) Monotherapies PD-1 Inhibitor: Pembrolizumab Multiple small studies have evaluated the efficacy of immune checkpoint inhibitors as monotherapy in BTC. Pembrolizumab, a highly selective, hum...